Abstract Because of bacterial resistance, current antibiotic consumption is reinforced by past use, and future utility is lower. The purpose of this article is to provide evidence on habit and addictive behavior toward antibiotics by exploring variations in the average consumption of antibiotics across 20 Italian regions. Using a balanced panel data set (2000-2009), we estimate myopic and rational addiction models, in which antibiotic consumption depends upon demographic and socioeconomic characteristics of the population, the supply of health care in the community, antibiotic price, and the "capital stock" of endogenous bacterial resistance measured by past and future consumption. Our empirical evidence shows that past antibiotic consumption stimulates current consumption and is also consistent with the rational addiction hypothesis. The low price elasticity of antibiotic demand suggests that policy measures targeted at antibiotic co-payments may not be effective in controlling antibiotic consumption. There is scope for other policy interventions, such as incentives and information campaigns targeted at doctors.
Introduction
Antibiotic misuse increases the threat of bacterial resistance, which in turn reduces antibiotic effectiveness over time (Elbasha 2003; Laxminarayan and Brown 2001) . It has been suggested that efforts to restrict antibiotic use in outpatients have not been very successful since no central agent, such as a hospital administrator or infection control committee, can enforce an antibiotic policy (Harbarth and Samore 2005) . Understanding of the dynamics of antibiotic consumption may help shape appropriate measures of public intervention to optimize the use of antimicrobials. The empirical literature is lacking in this respect.
Recent theoretical studies on the economics of antibiotics suggest that consumers make inter-temporal decisions. To some extent, antibiotics are similar to addictive goods since individuals may develop dependence or experience persistent attitudes toward consumption. Also, current antibiotic consumption may be affected by past consumption because of endogenous bacterial resistance. Static empirical models of antibiotic demand do not consider the process of adjustment toward optimal levels of antibiotic consumption.
The mechanism of transmission of antimicrobial resistance is described by the basic SIS epidemiological model, which is used, for instance, in recent theoretical studies by Herrmann and Gaudet (2009) and Wilen and Msangi (2003) . The SIS model assumes that the population is partitioned into infected individuals and individuals in good health. Uninfected individuals can become infected through contact with the infected population and individuals can be infected by a drug-resistant strain or a drug-susceptible strain. The transmission of drug-resistant strains to healthy individuals depends on the number and the speed of contacts among individuals. Some individuals infected with a drug-resistant strain naturally recover, but the rate of recovery for those treated with antibiotics remains unchanged.
In this paper, we propose a dynamic approach to investigate antibiotic use in outpatient care that hypothesizes that antibiotic consumption is affected by antibiotic inefficacy, i.e., the stock of bacterial resistance to antimicrobials. The level of inefficacy represents a bad that is indirectly measurable by means of past and future antibiotic use.
Individuals may be myopic in the sense that the effect of present antibiotic consumption on future consumption is not taken into account in their consumption choices. In this case, past consumption is presumed to affect present consumption only through the reduced level of antibiotic effectiveness. Conversely, patients may be aware of future implications of antibiotic use in terms of reduced antibiotic effectiveness. The plausibility of this assumption is also supported by the trust patients place in their doctors, whose superior knowledge of the implications of antibiotic treatment drives patients' decisions. This may imply that addiction to antibiotics is rational. If consumers' perceived benefits from antibiotic prescriptions outweigh the small uncertain costs associated with increased resistance (Brown and Layton 1996) , rational agents may not restrain from increasing consumption over time.
